The original article [1] contains errors in Figure 3i, Figure 6c and Figure S9:

1. 1.

   In Fig. 3i, the legends of the line chart were marked incorrectly.

   

   i Immunofluorescence analysis of co-localization between LA (green, FITC) and different subcellular compartments (red, early endosome, lysosome or endoplasmic reticulum) in immature DCs (blue, DAPI, nuclear) (n = 3)

   Full size image

2. 2.

   In Fig. 6c, the panel of ISA CD8a⁺ group was unintentionally duplicated onto the panel of YL-ISA NK1.1⁺ group.

   

   c Representative immunohistochemical staining of CD8a and NK1.1 in subcutaneously transplanted tumour tissues

   Full size image

3. 3.

   In Figure S9, the panel of LA-ISA Liver group was misused.

The corrected figures are presented ahead, and the changes do not affect the conclusions of the paper.

1. 1.

   Yu Z, Liu W, He Y, Sun M, Yu J, Jiao X, Han Q, Tang H, Zhang B, Xian Y, et al. HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8(+) T and NK cells: a novel therapeutic tumour vaccine. J Hematol Oncol. 2021;14(1):71. https://doi.org/10.1186/s13045-021-01081-7.

   CAS Article PubMed PubMed Central Google Scholar

Download references

1. Zhaojin Yu, Wensi Liu and Ying He have contributed equally to this work

Affiliations

1. Department of Pharmacology, School of Pharmacy, China Medical University, No. 13, Beihai Road, Dadong District, Shenyang, Liaoning Province, China

   Zhaojin Yu, Wensi Liu, Ying He, Mingli Sun, Jiankun Yu, Xue Jiao, Qiang Han, Haichao Tang, Bing Zhang, Yunkai Xian, Jing Qi, Jing Gong, Jianping Li & Minjie Wei

2. Liaoning Key Laboratory of Molecular Targeted Antitumour Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Centre, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumours, Ministry of Education, China Medical University, No.77, Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province, China

   Zhaojin Yu, Wensi Liu, Ying He, Mingli Sun, Jiankun Yu, Xue Jiao, Haichao Tang, Bing Zhang, Yunkai Xian, Jing Qi, Jing Gong & Minjie Wei

3. Liaoning Medical Diagnosis and Treatment R&D Centre Co. Ltd., Shenyang, Liaoning Province, China

   Wang Xin

4. The Third Department of Medical Oncology, The Fourth Hospital of China Medical University, Shenyang City, Liaoning Province, China

   Ying He

5. Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No.77, Xiaoheyan Road, Dadong District, Shenyang, Liaoning Province, China

   Gang Shi & Rui Zhang

6. Department of Immunology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, China

   Fengping Shan

7. Transfusion Medicine Institute, Liaoning Blood Centre, Shenyang, Liaoning Province, China

   Jianping Li

8. Transfusion Medicine Institute, Harbin Blood Centre, Harbin, Heilongjiang Province, China

   Jianping Li

9. Department of Pharmacy, Harrison International Peace Hospital, Hengshui, Hebei Province, China

   Qiang Han

1. Zhaojin YuView author publications

   You can also search for this author in PubMed Google Scholar

2. Wensi LiuView author publications

   You can also search for this author in PubMed Google Scholar

3. Ying HeView author publications

   You can also search for this author in PubMed Google Scholar

4. Mingli SunView author publications

   You can also search for this author in PubMed Google Scholar

5. Jiankun YuView author publications

   You can also search for this author in PubMed Google Scholar

6. Xue JiaoView author publications

   You can also search for this author in PubMed Google Scholar

7. Qiang HanView author publications

   You can also search for this author in PubMed Google Scholar

8. Haichao TangView author publications

   You can also search for this author in PubMed Google Scholar

9. Bing ZhangView author publications

   You can also search for this author in PubMed Google Scholar

10. Yunkai XianView author publications

    You can also search for this author in PubMed Google Scholar

11. Jing QiView author publications

    You can also search for this author in PubMed Google Scholar

12. Jing GongView author publications

    You can also search for this author in PubMed Google Scholar

13. Wang XinView author publications

    You can also search for this author in PubMed Google Scholar

14. Gang ShiView author publications

    You can also search for this author in PubMed Google Scholar

15. Fengping ShanView author publications

    You can also search for this author in PubMed Google Scholar

16. Rui ZhangView author publications

    You can also search for this author in PubMed Google Scholar

17. Jianping LiView author publications

    You can also search for this author in PubMed Google Scholar

18. Minjie WeiView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Rui Zhang or Jianping Li or Minjie Wei.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file 1.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Cite this article

Yu, Z., Liu, W., He, Y. et al. Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine. J Hematol Oncol 14, 158 (2021). https://doi.org/10.1186/s13045-021-01176-1

Download citation

• Published: 29 September 2021

• DOI: https://doi.org/10.1186/s13045-021-01176-1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative